Clinical Trials Directory

Trials / Completed

CompletedNCT04832672

Sequence of Radiation and Targeted Therapy in Brain Metastases

The Optimal Sequence of Intracranial Radiotherapy Compared to Systematic Tyrosine Kinase Inhibitors for Gene-driven Brain Metastases in Targeted Treatment Era

Status
Completed
Phase
Study type
Observational
Enrollment
570 (actual)
Sponsor
Chinese Academy of Medical Sciences · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The investigators conducted a single institutional, retrospective cohort study to demonstrate the appropriate treatment strategy of upfront intracranial radiotherapy or upfront targeted therapy in patients with brain metastases, including an assessment of its feasibility and toxicity.

Conditions

Timeline

Start date
2010-10-01
Primary completion
2021-03-01
Completion
2021-03-01
First posted
2021-04-06
Last updated
2021-04-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04832672. Inclusion in this directory is not an endorsement.

Sequence of Radiation and Targeted Therapy in Brain Metastases (NCT04832672) · Clinical Trials Directory